8IS5
| |
8IS4
| Structure of an Isocytosine specific deaminase Vcz in complexed with 5-FU | Descriptor: | 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, 5-FLUOROURACIL, GLYCEROL, ... | Authors: | Guo, W.T, Li, X.J, Wu, B.X. | Deposit date: | 2023-03-20 | Release date: | 2023-08-30 | Last modified: | 2023-09-20 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Structural characterization of an isocytosine-specific deaminase VCZ reveals its application potential in the anti-cancer therapy. Iscience, 26, 2023
|
|
7VSK
| Crystal structure of E.coli pseudouridine kinase PsuK complexed with pseudouridine. | Descriptor: | 5-[(2~{S},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-1~{H}-pyrimidine-2,4-dione, PfkB domain protein | Authors: | Li, K.J, Li, X.J, Wu, B.X. | Deposit date: | 2021-10-26 | Release date: | 2022-06-22 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (2.31 Å) | Cite: | Structure Characterization of Escherichia coli Pseudouridine Kinase PsuK. Front Microbiol, 13, 2022
|
|
7VKP
| |
7W93
| Crystal structure of E.coli pseudouridine kinase PsuK complexed with N1-methyl-pseudouridine | Descriptor: | 5-[(2S,3R,4S,5R)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-1-methyl-pyrimidine-2,4-dione, POTASSIUM ION, PfkB domain protein | Authors: | Li, K.J, Li, X.J, Wu, B.X. | Deposit date: | 2021-12-09 | Release date: | 2022-06-22 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Structure Characterization of Escherichia coli Pseudouridine Kinase PsuK. Front Microbiol, 13, 2022
|
|
7WW2
| Structure of an Isocytosine specific deaminase Vcz | Descriptor: | 8-oxoguanine deaminase, ZINC ION | Authors: | Li, X.J, Wu, B.X. | Deposit date: | 2022-02-12 | Release date: | 2023-02-22 | Last modified: | 2023-09-20 | Method: | X-RAY DIFFRACTION (2.7 Å) | Cite: | Structural characterization of an isocytosine-specific deaminase VCZ reveals its application potential in the anti-cancer therapy. Iscience, 26, 2023
|
|
5M6U
| HUMAN PI3KDELTA IN COMPLEX WITH LASW1579 | Descriptor: | 4-azanyl-6-[[(1~{S})-1-(4-oxidanylidene-3-phenyl-pyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile, Phosphatidylinositol 3-kinase regulatory subunit alpha, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Authors: | Segarra, V, Hernandez, B, Lozoya, E, Blaesse, M, Hoeppner, S, Jestel, A. | Deposit date: | 2016-10-26 | Release date: | 2017-02-01 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (2.85 Å) | Cite: | Discovery of a Potent, Selective, and Orally Available PI3K delta Inhibitor for the Treatment of Inflammatory Diseases. ACS Med Chem Lett, 8, 2017
|
|